Physicochemical Analysis, Identification and Characterization of drug Irbesartan and Triamterene
DOI:
https://doi.org/10.63682/jns.v13i1.7315Keywords:
Drugs, Identification, FTIRAbstract
The study paper focuses on the physicochemical analysis and structural elucidation of two pharmacologically important compounds: Irbesartan, an angiotensin II receptor antagonist, and Triamterene, a potassium-sparing diuretic. The identification and characterization were carried out using various analytical and spectroscopic techniques including UV-Visible spectroscopy, FTIR (Fourier Transform Infrared Spectroscopy), and melting point determination. Organoleptic properties such as color, odor, and appearance were also assessed. The λmax of both drugs was determined in appropriate solvents to establish their UV absorption profiles. FTIR analysis confirmed the presence of functional groups characteristic to each drug, providing molecular fingerprint confirmation. Melting point analysis further supported the purity and identity of the samples. These characterization studies are essential for ensuring the quality, efficacy, and safety of pharmaceutical formulations containing Irbesartan and Triamterene, and they provide a strong foundation for further formulation development and quality control.
Downloads
Metrics
References
Görög, S. (2015). Identification in drug quality control and drug research. TrAC Trends in Analytical Chemistry, 69, 114-122.
Gillis, J. C., & Markham, A. (1997). Irbesartan: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension. Drugs, 54, 885-902.
Carey, R. A., Beg, M. M., McNally, C. F., & Tannenbaum, P. (1984). Triamterene and renal lithiasis: a review. Clinical Therapeutics, 6(3), 302-309.
Patil, A., Bhide, S., Bookwala, M., Soneta, B., Shankar, V., Almotairy, A., ... & Narasimha Murthy, S. (2018). Stability of organoleptic agents in pharmaceuticals and cosmetics. AAPS pharmscitech, 19, 36-47.
Dorofeev, V. L., Arzamastsev, A. P., & Veselova, O. M. (2004). Melting Point Determination for the Analysis of Drugs of the Fluoroquinolone Group. Pharmaceutical Chemistry Journal, 38(6).
Saha, R. N., Sajeev, C., Jadhav, P. R., Patil, S. P., & Srinivasan, N. (2002). Determination of celecoxib in pharmaceutical formulations using UV spectrophotometry and liquid chromatography. Journal of pharmaceutical and biomedical analysis, 28(3-4), 741-751.
Jouyban, A., & Fakhree, M. A. (2012). Experimental and computational methods pertaining to drug solubility. Toxicity and drug testing, 1.
Singh, C., Rao, K., Yadav, N., Bansal, N., Vashist, Y., Kumari, S., & Chugh, P. (2023). A review: drug excipient iincompatiblity by ftir spectroscopy. Current Pharmaceutical Analysis, 19(5), 371-378.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
